GECC Form 4: Director Sold 44,661 Shares at $11.20 in Aug 2025
Great Elm Strategic Partnership I, LLC reported insider sales of Great Elm Capital Corp. (GECC) common stock on August 21 and August 22, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Great Elm Strategic Partnership I, LLC reported insider sales of Great Elm Capital Corp. (GECC) common stock on August 21 and August 22, 2025. The filing shows a sale of 26,705 shares on 08/21/2025 and a sale of 17,956 shares on 08/22/2025, each at a price of $11.20 per share. Following the 08/21 sale the reporting person beneficially owned 1,712,921 shares, and after the 08/22 sale beneficial ownership was 1,694,965 shares. The reporting person is identified as a director of the issuer. The Form 4 was signed by Adam M. Kleinman, attorney-in-fact on 08/22/2025.
Positive
- Timely disclosure: Sales were reported on Form 4 with transaction dates and post-transaction ownership figures
- Transparency: Filing includes exact share counts and sale prices ($11.20), allowing clear tracking of insider activity
Negative
- Insider sales: Reporting person sold a total of 44,661 shares across two days, reducing beneficial ownership
- No stated reason: Filing does not specify purpose of sales or whether transactions were under a 10b5-1 plan
Insights
TL;DR: Director sold a total of 44,661 GECC shares across two days at $11.20 each; change appears routine and disclosed.
The Form 4 discloses two open-market sales by Great Elm Strategic Partnership I, LLC totaling 44,661 shares at $11.20 per share on consecutive days. These sales reduced beneficial ownership from 1,712,921 to 1,694,965 shares. The filing identifies the reporting entity as a director, and signatures indicate timely attorney-in-fact execution. There is no accompanying information about reasons for sale or any derivative transactions. For investors, the data documents insider liquidity but does not by itself indicate firm-level operational or financial change.
TL;DR: Disclosure meets Section 16 reporting requirements; sales were properly reported but provide limited governance insight.
The disclosure shows compliance with Section 16 reporting: the reporting person, a director, reported two sales and the Form 4 was signed by an attorney-in-fact. The record includes transaction codes and post-transaction beneficial ownership counts, enabling transparency. Absent additional context (planned sale, Rule 10b5-1 plan, or related-party explanation), the trades are routine insider sales from a governance perspective. No derivatives, amendments, or exceptions are reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 17,956 | $11.20 | $201K |
| Sale | Common Stock | 26,705 | $11.20 | $299K |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions does the GECC Form 4 report show?
Who is the reporting person on the GECC Form 4?
What was the reporting person’s beneficial ownership after the reported sales?
Were any derivative securities or 10b5-1 plans disclosed in the filing?
Who signed the Form 4 and when?
AI-generated analysis. How Rhea-AI works. Not financial advice.